Perioperative Medicine and Intensive Care, Karolinska University Hospital, Solna, Sweden.
Section of Anesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.
Crit Care Med. 2021 Mar 1;49(3):462-471. doi: 10.1097/CCM.0000000000004896.
To describe opioid use after ICU admission, identify factors associated with chronic opioid use after critical care, and determine if chronic opioid use is associated with an increased risk of death.
Retrospective cohort study.
Sweden including all registered ICU admissions between 2010 and 2018.
Adults surviving the first two quarters after ICU admission were eligible for inclusion. A total of 265,496 patients were screened and 61,094 were ineligible.
Admission to intensive care.
Among 204,402 individuals included in the cohort, 22,138 developed chronic opioid use following critical care. Mean opioid consumption peaked after admission followed by a continuous decline without returning to baseline during follow-up of 24 months. Factors associated with chronic opioid use included high age, female sex, presence of comorbidities, preadmission opioid use, and ICU length of stay greater than 2 days. Adjusted hazard ratio for death 6-18 months after admission for chronic opioid users was 1.7 (95% CI, 1.6-1.7; p < 0.001). In the subset of patients not using opioids prior to admission, similar findings were noted.
Mean opioid consumption is increased 24 months after ICU admission despite the lack of evidence for long-term opioid treatment. Given the high number of ICU entries and risk of excess mortality for chronic users, preventing opioid misuse is important when improving long-term outcomes after critical care.
描述 ICU 入院后的阿片类药物使用情况,确定与重症监护后慢性阿片类药物使用相关的因素,并确定慢性阿片类药物使用是否与死亡风险增加相关。
回顾性队列研究。
包括 2010 年至 2018 年期间所有登记的 ICU 入院的瑞典。
在 ICU 后两个季度存活下来的成年人有资格入选。共筛选了 265496 名患者,其中 61094 名患者不合格。
入住重症监护病房。
在队列中 204402 名个体中,22138 名在重症监护后发展为慢性阿片类药物使用。阿片类药物的平均消耗量在入院后达到峰值,随后持续下降,在 24 个月的随访期间未恢复到基线。与慢性阿片类药物使用相关的因素包括年龄较大、女性、合并症、入院前阿片类药物使用和 ICU 住院时间超过 2 天。慢性阿片类药物使用者在入院后 6-18 个月死亡的调整危险比为 1.7(95%CI,1.6-1.7;p < 0.001)。在未入院前使用阿片类药物的患者亚组中也观察到了类似的发现。
尽管缺乏长期阿片类药物治疗的证据,但 ICU 入院后 24 个月阿片类药物的平均消耗量仍增加。鉴于 ICU 入住人数众多且慢性使用者的死亡风险增加,在改善重症监护后长期结局时,防止阿片类药物滥用非常重要。